 |
|
|
|
|
|
 |
|
|
| Your resource for specialty nutritional supplements, books, DVDs, resources for better living, health news & more! |
|
|
|
 |
|
|
| |
|
Search our extensive library for information, solutions & support
|
|
|
|
|
February 2, 2005
BMC Psychiatry. 2004 Nov 11;4(1):38.
Shippy RA, Mendez D, Jones K, Cergnul I, Karpiak SE.
ACRIA (AIDS Community Research Initiative of America), 230 West 38th St, 17th Floor, New York, NY 10018, USA. ashippy@acria.org
BACKGROUND: This study reports on clinical data from an 8-week open-label study of 20 HIV-seropositive individuals, diagnosed with Major Depressive Disorder (DSM-IV), who were treated with SAM-e (S-Adenosylmethionine). SAM-e may be a treatment alternative for the management of depression in a population reluctant to add another "pill" or another set of related side effects to an already complex highly active antiretroviral therapy (HAART) regimen.
METHODS: The Hamilton Rating Scale for Depression (HAM-D) and the Beck Depression Inventory (BDI) were used to assess depressive symptomatology from 1,2,4,6 and 8 weeks after initiation of treatment with SAM-e.
RESULTS: Data show a significant acute reduction in depressive symptomatology, as measured by both the HAM-D and the BDI instruments.
CONCLUSIONS: SAM-e has a rapid effect evident as soon as week 1 (p < .001), with progressive decreases in depression symptom rating scores throughout the 8 week study.
PMID: 15538952 [PubMed - in process]
|
|
|
|
|
|
|
|
|
|
 |
 |
NEWS HEARD 'ROUND THE WORLD: Dr. Kenny De Meirleir Announces He has Revealed the True Nature of ME/C... [more]
Dietary supplement Healthy Curb for reducing weight, girth, body mass, appetite and fatigue while im... [more]
Does varicella-zoster virus infection of the peripheral ganglia cause Chronic Fatigue Syndrome? – So... [more]
The Essential Nutrient Magnesium - Key to Mitochondrial ATP Production and Much More [more]
The May 27-28 CFSAC meeting – A landmark event shared worldwide via video coverage... Now what? [more]
|
|
|
